MAVS and viral infectious disease: Our results confirmed that the relative amount of UDP-N-acetylglucosamine increased during the first replication cycle of the virus, which may increase the glycosylation of MAVS, helping it to form prion-like aggregates to activate an antiviral response in innate immunity after viral infection.